STROLLO, ROCKY
 Distribuzione geografica
Continente #
AS - Asia 2.439
NA - Nord America 193
EU - Europa 92
SA - Sud America 4
OC - Oceania 3
Totale 2.731
Nazione #
SG - Singapore 2.259
US - Stati Uniti d'America 185
CN - Cina 98
HK - Hong Kong 68
IT - Italia 28
GB - Regno Unito 22
DE - Germania 16
NL - Olanda 8
IN - India 5
SE - Svezia 5
AT - Austria 4
CA - Canada 4
JP - Giappone 4
AU - Australia 3
TR - Turchia 3
BR - Brasile 2
FI - Finlandia 2
MX - Messico 2
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
GP - Guadalupe 1
ID - Indonesia 1
IE - Irlanda 1
MS - Montserrat 1
PE - Perù 1
PL - Polonia 1
RS - Serbia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 2.731
Città #
Singapore 112
Hong Kong 68
Hefei 40
Ashburn 31
Beijing 27
Dallas 27
Boardman 21
London 16
Shanghai 14
Santa Clara 11
Los Angeles 8
Rome 7
Amsterdam 6
Denver 6
Munich 6
San Francisco 6
Stockholm 5
Council Bluffs 3
New York 3
Tokyo 3
Vienna 3
Bologna 2
Brooklyn 2
Chicago 2
Ferentino 2
Livorno 2
Melbourne 2
Mexico City 2
Mirabella Eclano 2
Montreal 2
Poplar 2
Pune 2
Seattle 2
Secaucus 2
Turku 2
Viareggio 2
A Coruña 1
Baie-Mahault 1
Belgrade 1
Bexleyheath 1
Boston 1
Brno 1
Canberra 1
Cannock 1
Changchun 1
Changsha 1
Chennai 1
Cleveland 1
Dublin 1
Lima 1
Milan 1
New Delhi 1
Norfolk 1
Quito 1
Sona 1
St Louis 1
São Paulo 1
Toronto 1
Warsaw 1
Washington 1
Xiamen 1
Totale 478
Nome #
Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes 218
Increased sclerostin and bone turnover after diet-induced weight loss in type 2 diabetes: a post hoc analysis of the MADIAB trial 203
HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus 193
Computed tomography highlights increased visceral adiposity associated with critical illness in covid-19 187
Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies 187
DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19? 186
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity 183
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths 178
Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes 176
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross‐sectional study 170
Increased carotid thickness in subjects with recently-diagnosed diabetes from rural Cameroon 116
Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency 95
Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritis 93
Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes 92
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 91
The D-side of COVID-19: musculoskeletal benefits of vitamin D and beyond 88
Risk factors for fragility fractures in type 1 diabetes 88
Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity 74
Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength 66
Prevaccination Glucose Time in Range Correlates With Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes 58
Totale 2.742
Categoria #
all - tutte 10.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 0 0 0 0 0 0 0 1 1 26
2022/202324 0 0 2 4 1 0 0 1 0 4 12 0
2023/202462 2 6 4 3 6 20 0 8 1 4 2 6
2024/20252.448 15 43 48 12 4 35 9 3 37 131 1.030 1.081
2025/2026180 72 26 33 49 0 0 0 0 0 0 0 0
Totale 2.742